statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews

Latest Ratings for COLL
 DateFirmActionFromTo Feb 2022Piper SandlerMaintainsOverweight Feb 2022HC Wainwright & Co.MaintainsBuy Feb 2022NeedhamMaintainsBuy
 View More Analyst Ratings for COLL...

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...

Collegium Pharmaceutical (COLL, $40.9) RSI Indicator left the overbought zone on March 27, 2024

This is a signal that COLL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Collegium Pharmaceutical (COLL, $39.93) RSI Indicator left the overbought zone on March 26, 2024

Collegium Pharmaceutical Reaches Analyst Target Price

In recent trading, shares of Collegium Pharmaceutical Inc (COLL) have crossed above the average analyst 12-month target price of 40.00, changing hands for 40.16/share. When a stock reaches...

Collegium Pharmaceutical (COLL, $39.66) Stochastic Oscillator left the overbought zone on March 21, 2024

This is a signal that COLL's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Collegium Pharmaceutical (COLL, $37.96) RSI Indicator left the overbought zone on March 19, 2024

Collegium Pharmaceutical (COLL, $39.09) price may drop as it broke higher Bollinger Band on Mar 15, 2024

This price move could be a signal that COLL may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Collegium Pharmaceutical (COLL, $39.09) RSI Indicator left the overbought zone on March 15, 2024

The volume for Collegium Pharmaceutical stock increased for one day, resulting in a record-breaking daily growth of 353% of the 65-Day Volume Moving Average

COLL's total volume now sits at 2M. The +2.79% price change was insignificant, leaving IBM's price at $39.09...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Volume	376,680.00
52-Wk High	$40.95
52-Wk Low	$20.95

COLL Collegium Pharmaceutical Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community